Official announcements
Search narrowed by
Recall
|
Medicines
|
07/04/2017
The marketing authorization holder has informed its supplied customers in a letter dated April 6, 2017, that individual bottles filled with 100 ml of distilled water were included in the packaging of Buerlecithin liquid 1000 ml. For this reason, this…
Safety warnings
|
Medicines
|
23/03/2017
Worldwide, there were two complaints outside of Austria that the auto-injector did not work correctly. Meda Pharma GmbH is therefore recalling a batch of EpiPen 300 micrograms in Austria.
Recall
|
Medicines
|
23/03/2017
The marketing authorization holder informed its supplied customers in a letter dated March 23, 2017, that there is a very low probability that the auto-injector of batch 5FA665N does not work correctly. Worldwide, there were two customer complaints…
Recall
|
Medicines
|
23/02/2017
The marketing authorization holder has informed its supplied customers in a letter dated 22.2.2017 that a possible contamination with another active ingredient has been discovered at the manufacturer. For this reason, a recall of the above-mentioned…
Recall
|
Medicines
|
19/12/2016
The marketing authorization holder informed its supplied customers in a letter dated December 15, 2016, that the vials may have cracks in the glass. Therefore, the affected batch is being recalled as a precautionary measure. The company is not aware…
Recall
|
Medicines
|
16/12/2016
In a letter dated December 13, 2016, the marketing authorization holder informed its customers that the above-mentioned batches of "Sertraline Sandoz" and "Lamotrigine Sandoz" are being recalled. During the routine incoming goods inspection on the…
Recall
|
Medicines
|
24/10/2016
The marketing authorization holder informed its supplied customers in a letter dated October 12, 2016, that an impurity, "lmpurity D", was detected in the course of stability tests, which in the measured concentration does not indicate any health…
Recall
|
Medicines
|
24/10/2016
The marketing authorization holder informed its supplied customers in a letter dated October 13, 2016, that an impurity, "lmpurity D", was detected during stability tests. In the measured concentration there is no health risk for the patients. A…
Recall
|
Medicines
|
18/10/2016
Gedeon Richter Plc has informed their supplied customers by letter dated 12/10/2016 that above mentioned batches of "Lisvy 60 microgram/24 hours + 13 microgram/24 hours Transdermal Patch" are recalled. Stability data for these batches indicated a…
Recall
|
Medicines
|
14/10/2016
CSL Behring as distributor of the product Helixate NexGen has, in coordination with the marketing authorization holder Bayer Pharma AG, informed its supplied customers in a letter dated October 11, 2016, that the above mentioned batches of Helixate…